{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:48:02Z","timestamp":1792590482718,"version":"4.5.0"},"reference-count":10,"publisher":"MyJove Corporation","issue":"228","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70329","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:01:00Z","timestamp":1771632060000},"source":"Crossref","is-referenced-by-count":0,"title":["Characterizing Tumor-Induced Ataxia in a Vestibular Schwannoma Mouse Model"],"prefix":"10.3791","author":[{"given":"Simeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Day Caven","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-4-16","type":"journal-article","article-title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet journal of rare diseases","author":"Evans","year":"2009","unstructured":"Evans, D. R. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet journal of rare diseases. (2009).","journal-title":"Orphanet journal of rare diseases"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1097\/00129492-200501000-00016","type":"journal-article","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought","author":"Evans","year":"2005","unstructured":"Evans, D.G. et al. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otology & neurotology. (2005).","journal-title":"Otology & neurotology"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad089","type":"journal-article","article-title":"Vestibular dysfunction in NF2-related schwannomatosis","author":"Madhani","year":"2023","unstructured":"Madhani, A. S. et al. Vestibular dysfunction in NF2-related schwannomatosis. Brain Communications. (2023).","journal-title":"Brain Communications"},{"key":"ref4","type":"journal-article","article-title":"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma","author":"Chen","year":"2019","unstructured":"Chen, J. et al. A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma. Nature protocols. (2019).","journal-title":"Nature protocols"},{"key":"ref5","type":"journal-article","article-title":"Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis","author":"Lu","year":"2024","unstructured":"Lu, S. et al. Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis. Cancers. (2024).","journal-title":"Cancers"},{"key":"ref6","type":"journal-article","article-title":"Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models","author":"Zhao","year":"2018","unstructured":"Zhao, Y. et al. Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. Proceedings of the National Academy of Sciences. (2018).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008316","type":"journal-article","article-title":"Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases","author":"Chung","year":"2009","unstructured":"Chung, E. et al. Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PloS one. (2009).","journal-title":"PloS one"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2009.28","type":"journal-article","article-title":"Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo","author":"Tannous","year":"2009","unstructured":"Tannous, B. A. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nature protocols. (2009).","journal-title":"Nature protocols"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1216078109","type":"journal-article","article-title":"Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases","author":"Kodack","year":"2012","unstructured":"Kodack, D. P. et al. Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases. Proceedings of the National Academy of Sciences. (2012).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.3791\/1787","type":"journal-article","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","author":"Guyenet","year":"2010","unstructured":"Guyenet, S. J. et al. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. Journal of visualized experiments: JoVE. (2010).","journal-title":"Journal of visualized experiments: JoVE"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/70329\/characterizing-tumor-induced-ataxia-vestibular-schwannoma-mouse","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:23:32Z","timestamp":1792589012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70329\/characterizing-tumor-induced-ataxia-vestibular-schwannoma-mouse"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":10,"journal-issue":{"issue":"228","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70329","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}